Key facts
- VedaLab’s last known valuation is $137.5M (Sep 2014).
- It has raised $12.1M; the latest was PE Growth/Expansion in Jan 2025.
- Notable investors include Turenne Groupe, Sodero.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for VedaLab
- ·The full record, as it builds
Funding rounds
No funding rounds for VedaLab are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About VedaLab
Developer and manufacturer of rapid medical diagnostic tests and kits in Alençon, France. The company specializes in research and development and the production of rapid immunochromatographic tests and kits for the human healthcare, veterinary, agribusiness and environmental diagnostic sectors.
- Sector
- Healthcare
- HQ
- Alencon, France
- Founded
- 1991
- Employees
- 50
- Website
- vedalab.com/
- Ownership
- Privately Held (backing)
VedaLab doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in VedaLab shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on VedaLab in its N-PORT filings yet. We sweep new filings monthly.